Cytogen (XKRX:217330) Other Financing : ₩36,767 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cytogen Other Financing?

Cytogen's Other Financing for the three months ended in Mar. 2024 was ₩2 Mil.

Cytogen's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₩36,767 Mil.

Cytogen Other Financing Historical Data

The historical data trend for Cytogen's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Other Financing Chart

Cytogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Financing

Get a 7-Day Free Trial

42.20

59.72

43.29

-1,664.94

-369.50

Cytogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Financing	Get a 7-Day Free Trial															-0.58	-3,236.10	-32.15	40,033.15	1.85

Cytogen Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩36,767 Mil.

Cytogen Other Financing Related Terms

Thank you for viewing the detailed overview of Cytogen's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytogen (XKRX:217330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854

Website

http://www.cytogenlab.com

Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines